{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:17:03Z","timestamp":1768810623123,"version":"3.49.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Merozoite invasion of the erythrocytes in humans is a key step in the pathogenesis of malaria. The proteins involved in the merozoite invasion could be potential targets for the development of malaria vaccines. Novel viral-vector-based malaria vaccine regimens developed are currently under clinical trials. Vesicular stomatitis virus (VSV) is a single-stranded negative-strand RNA virus widely used as a vector for virus or cancer vaccines. Whether the VSV-based malarial vaccine is more effective than conventional vaccines based on proteins involved in parasitic invasion is still unclear. In this study, we have used the reverse genetics system to construct recombinant VSVs (rVSVs) expressing apical membrane protein 1 (AMA1), rhoptry neck protein 2 (RON2), and reticulocyte-binding protein homolog 5 (RH5), which are required for <jats:italic>Plasmodium falciparum<\/jats:italic> invasion. Our results showed that VSV-based viral vaccines significantly increased <jats:italic>Plasmodium<\/jats:italic>-specific IgG levels and lymphocyte proliferation. Also, VSV-PyAMA1 and VSV-PyRON2sp prime-boost regimens could significantly increase the levels of IL-2 and IFN-\u03b3-producing by CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells and suppress invasion <jats:italic>in vitro<\/jats:italic>. The rVSV prime-protein boost regimen significantly increase <jats:italic>Plasmodium<\/jats:italic> antigen-specific IgG levels in the serum of mice compared to the homologous rVSV prime-boost. Furthermore, the protective efficacy of rVSV prime protein boost immunization in the mice challenged with <jats:italic>P. yoelii<\/jats:italic> 17XL was better compared to traditional antigen immunization. Together, our results show that VSV vector is a novel strategy for malarial vaccine development and preventing the parasitic diseases.<\/jats:p>","DOI":"10.3389\/fmicb.2022.1042414","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:04:06Z","timestamp":1669280646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Vesicular stomatitis virus-based vaccine targeting plasmodium blood-stage antigens elicits immune response and protects against malaria with protein booster strategy"],"prefix":"10.3389","volume":"13","author":[{"given":"Yifan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-taek","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunsheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2147\/RMHP.S219294","article-title":"Towards eradication of malaria: is the WHO's RTS,S\/AS01 vaccination effective enough?","volume":"14","author":"Arora","year":"2021","journal-title":"Risk Manag. Healthc Pol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"11802","DOI":"10.1038\/s41598-020-67877-8","article-title":"Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations","volume":"10","author":"Azasi","year":"2020","journal-title":"Sci. Rep."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.parint.2013.09.001","article-title":"In vivo imaging in NHP models of malaria: challenges, progress and outlooks","volume":"63","author":"Beignon","year":"2014","journal-title":"Parasitol. Int."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijpara.2016.06.002","article-title":"Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria","volume":"47","author":"Boyle","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","article-title":"Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter","volume":"73","author":"Buchholz","year":"1999","journal-title":"J. Virol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.vaccine.2012.10.106","article-title":"A full-length recombinant plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants","volume":"31","author":"Bustamante","year":"2013","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.chom.2020.07.018","article-title":"Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/14760584.2021.1874924","article-title":"The challenges of a circumsporozoite protein-based malaria vaccine","volume":"20","author":"Chatterjee","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e00236-19","DOI":"10.1128\/IAI.00236-19","article-title":"Antibody-dependent, gamma interferon-independent sterilizing immunity induced by a subunit malaria vaccine","volume":"87","author":"Chawla","year":"2019","journal-title":"Infect. Immun."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7001a1","article-title":"Use of Ebola vaccine: recommendations of the advisory committee on immunization practices, United States, 2020","volume":"70","author":"Choi","year":"2021","journal-title":"MMWR Recomm. Rep."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"694759","DOI":"10.3389\/fimmu.2021.694759","article-title":"Safety and immunogenicity of ChAd63\/MVA Pfs25-IMX313 in a phase I first-in-human trial","volume":"12","author":"de Graaf","year":"2021","journal-title":"Front. Immunol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.mib.2018.09.003","article-title":"Rodent malaria models: insights into human disease and parasite biology","volume":"46","author":"De Niz","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.chom.2014.11.017","article-title":"A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys","volume":"17","author":"Douglas","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4049\/jimmunol.1302045","article-title":"Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5","volume":"192","author":"Douglas","year":"2014","journal-title":"J. Immunol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.1016\/j.vaccine.2015.09.094","article-title":"Progress with viral vectored malaria vaccines: a multi-stage approach involving \u201cunnatural immunity\u201d","volume":"33","author":"Ewer","year":"2015","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1080\/21645515.2019.1649532","article-title":"Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens","volume":"15","author":"Fathi","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.3389\/fimmu.2018.02769","article-title":"Novel strategies for malaria vaccine design","volume":"9","author":"Frimpong","year":"2018","journal-title":"Front. Immunol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"8122","DOI":"10.1073\/pnas.83.21.8122","article-title":"Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase","volume":"83","author":"Fuerst","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12835","article-title":"Using two phases of the CD4 T cell response to blood-stage murine malaria to understand regulation of systemic immunity and placental pathology in Plasmodium falciparum infection","volume":"293","author":"Gbedande","year":"2020","journal-title":"Immunol. Rev."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"594653","DOI":"10.3389\/fimmu.2020.594653","article-title":"Naturally acquired humoral immunity against Plasmodium falciparum malaria","volume":"11","author":"Gonzales","year":"2020","journal-title":"Front. Immunol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","article-title":"Drug resistance in Plasmodium","volume":"16","author":"Haldar","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/infdis\/jiu579","article-title":"Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals","volume":"211","author":"Hodgson","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e1008840","DOI":"10.1371\/journal.ppat.1008840","article-title":"Contributions of IFN-gamma and granulysin to the clearance of Plasmodium yoelii blood stage","volume":"16","author":"Hojo-Souza","year":"2020","journal-title":"PLoS Pathog."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.12829","article-title":"Novel viral vectors in infectious diseases","volume":"153","author":"Humphreys","year":"2018","journal-title":"Immunology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"S404","DOI":"10.1086\/520591","article-title":"Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever","volume":"196","author":"Jones","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41591-018-0117-4","article-title":"Cytotoxic CD8(+) T cells recognize and kill Plasmodium vivax-infected reticulocytes","volume":"24","author":"Junqueira","year":"2018","journal-title":"Nat. Med."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.3389\/fimmu.2019.02917","article-title":"Cytotoxic T cell-derived Granzyme B is increased in severe plasmodium falciparum malaria","volume":"10","author":"Kaminski","year":"2019","journal-title":"Front. Immunol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/vaccines8030363","article-title":"Evaluation of chimpanzee adenovirus and MVA expressing TRAP and CSP from plasmodium cynomolgi to prevent malaria relapse in nonhuman primates","volume":"8","author":"Kim","year":"2020","journal-title":"Vaccines"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1038\/mt.2014.109","article-title":"Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations","volume":"22","author":"Kimani","year":"2014","journal-title":"Mol. Ther."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/intimm\/dxq448","article-title":"Production of IFN-gamma by CD4(+) T cells in response to malaria antigens is IL-2 dependent","volume":"22","author":"Kimura","year":"2010","journal-title":"Int. Immunol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.imlet.2014.03.011","article-title":"Memory T cells maintain protracted protection against malaria","volume":"161","author":"Krzych","year":"2014","journal-title":"Immunol. Lett."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41577-019-0158-z","article-title":"T cell-mediated immunity to malaria","volume":"19","author":"Kurup","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1128\/IAI.72.8.4464-4470.2004","article-title":"Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune response","volume":"72","author":"Lalitha","year":"2004","journal-title":"Infect. Immun."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-micro-090817-062427","article-title":"The promise of a malaria vaccine-are we closer?","volume":"72","author":"Laurens","year":"2018","journal-title":"Annu. Rev. Microbiol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 vaccine (Mosquirix): an overview","volume":"16","author":"Laurens","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","article-title":"Recombinant vesicular stomatitis viruses from DNA","volume":"92","author":"Lawson","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e12781","DOI":"10.1111\/pim.12781","article-title":"Virus-like particles expressing Plasmodium berghei MSP-8 induce protection against P. berghei infection","volume":"42","author":"Lee","year":"2020","journal-title":"Parasite Immunol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.vaccine.2006.07.035","article-title":"Viral vectors for malaria vaccine development","volume":"25","author":"Li","year":"2007","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"101765","DOI":"10.1016\/j.jbc.2022.101765","article-title":"Glycosylphosphatidylinositol-anchored micronemal antigen (GAMA) interacts with the band 3 receptor to promote erythrocyte invasion by malaria parasites","volume":"298","author":"Lu","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.3389\/fimmu.2018.03071","article-title":"Protection against Marburg virus using a recombinant VSV-vaccine depends on T and B cell activation","volume":"9","author":"Marzi","year":"2018","journal-title":"Front. Immunol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cois.2019.12.001","article-title":"Effects of insecticide resistance and exposure on Plasmodium development in Anopheles mosquitoes","volume":"39","author":"Minetti","year":"2020","journal-title":"Curr. Opin. Insect Sci."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fimmu.2017.01008","article-title":"RTS,S\/AS01E malaria vaccine induces memory and polyfunctional T cell responses in a pediatric African phase III trial","volume":"8","author":"Moncunill","year":"2017","journal-title":"Front. Immunol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1038\/s41598-021-81711-9","article-title":"Assessing the functional impact of PfRh5 genetic diversity on ex vivo erythrocyte invasion inhibition","volume":"11","author":"Moore","year":"2021","journal-title":"Sci. Rep."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic diversity and protective efficacy of the RTS,S\/AS01 malaria vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41576-021-00349-5","article-title":"Advances and opportunities in malaria population genomics","volume":"22","author":"Neafsey","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-year efficacy of RTS,S\/AS01 malaria vaccine among young African children","volume":"374","author":"Olotu","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.3390\/ijms21134729","article-title":"Hotspots in Plasmodium and RBC receptor-ligand interactions: key pieces for inhibiting malarial parasite invasion","volume":"21","author":"Patarroyo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e96381","DOI":"10.1172\/jci.insight.96381","article-title":"Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions","volume":"2","author":"Payne","year":"2017","journal-title":"JCI Insight"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/infdis\/jiy565","article-title":"Detectable vesicular stomatitis virus (VSV)-specific humoral and cellular immune responses following VSV-Ebola virus vaccination in humans","volume":"219","author":"Poetsch","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"9317","DOI":"10.1128\/JVI.78.17.9317-9324.2004","article-title":"Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses","volume":"78","author":"Publicover","year":"2004","journal-title":"J. Virol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.pt.2020.04.003","article-title":"The RH5-CyRPA-Ripr complex as a malaria vaccine target","volume":"36","author":"Ragotte","year":"2020","journal-title":"Trends Parasitol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1016\/j.jmb.2019.05.018","article-title":"Blood-stage malaria parasite antigens: structure, function, and vaccine potential","volume":"431","author":"Salinas","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"101430","DOI":"10.1016\/j.smim.2020.101430","article-title":"New viral vectors for infectious diseases and cancer","volume":"50","author":"Sasso","year":"2020","journal-title":"Semin. Immunol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"612910","DOI":"10.3389\/fimmu.2021.612910","article-title":"Liver-directed AAV8 booster vaccine expressing Plasmodium falciparum antigen following adenovirus vaccine priming elicits sterile protection in a murine model","volume":"12","author":"Shahnaij","year":"2021","journal-title":"Front. Immunol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41541-017-0015-7","article-title":"A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection","volume":"2","author":"Srinivasan","year":"2017","journal-title":"NPJ Vacc."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"13275","DOI":"10.1073\/pnas.1110303108","article-title":"Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion","volume":"108","author":"Srinivasan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"10311","DOI":"10.1073\/pnas.1409928111","article-title":"Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria","volume":"111","author":"Srinivasan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/14760584.2021.1882309","article-title":"Correlates of malaria vaccine efficacy","volume":"20","author":"Stanisic","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"eabg2344","DOI":"10.1126\/scitranslmed.abg2344","article-title":"Functional human IgA targets a conserved site on malaria sporozoites","volume":"13","author":"Tan","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S1473-3099(19)30300-7","article-title":"Long-term incidence of severe malaria following RTS,S\/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial","volume":"19","author":"Tinto","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e0208328","DOI":"10.1371\/journal.pone.0208328","article-title":"First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children","volume":"13","author":"Tiono","year":"2018","journal-title":"PLoS One"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.pt.2011.04.002","article-title":"Focus on the ringleader: the role of AMA1 in apicomplexan invasion and replication","volume":"27","author":"Tyler","year":"2011","journal-title":"Trends Parasitol."},{"key":"ref63","volume-title":"World Malaria Report","year":"2021"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature13715","article-title":"Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies","volume":"515","author":"Wright","year":"2014","journal-title":"Nature"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1016\/j.vaccine.2014.05.052","article-title":"A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis","volume":"32","author":"Wu","year":"2014","journal-title":"Vaccine"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1038\/s41467-020-20228-7","article-title":"A single dose of recombinant VSV-G-spike vaccine provides protection against SARS-CoV-2 challenge","volume":"11","author":"Yahalom-Ronen","year":"2020","journal-title":"Nat. Commun."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3389\/fimmu.2019.02412","article-title":"A viral-vectored multi-stage malaria vaccine regimen with protective and transmission-blocking efficacies","volume":"10","author":"Yusuf","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1042414\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:04:09Z","timestamp":1669280649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1042414\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":67,"alternative-id":["10.3389\/fmicb.2022.1042414"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.1042414","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"article-number":"1042414"}}